Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

ACEP Shares Opioid Resources with FDA

By ACEP Now | on September 24, 2019 | 0 Comment
From the College
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

The U.S. Food and Drug Administration (FDA) is interested in the development of resources to reduce the use of opioids where alternatives exist, so ACEP shared its extensive opioid resources. To view those resources, click here. Our two opioid-related point-of-care tools—MAP (managing acute pain) and BUPE (buprenorphine)—are now available on our new app, emPOC, available through the Apple Store and Google Play.

You Might Also Like
  • ACEP’s New Point-of-Care App Is Transforming Bedside Care
  • ACEP15 Mobile App Hosts Conference Schedules, Syllabi, Surveys
  • Indivior, Drug to Fight Opioid Addiction, Approved by U.S. FDA
Explore This Issue
ACEP Now: Vol 38 – No 09 – September 2019

Topics: emPOC appFDAOpioid CrisisOpioidsPoint-of-CareTechnology

Related

  • June 2025 News from the College

    June 5, 2025 - 1 Comment
  • Tread Cautiously with Artificial Intelligence in Clinical Scenarios

    July 8, 2024 - 0 Comment
  • How to Manage Elderly Patient Pain without Opioids

    February 13, 2024 - 0 Comment

Current Issue

ACEP Now: July 2025

Download PDF

Read More

About the Author

ACEP Now

View this author's posts »

No Responses to “ACEP Shares Opioid Resources with FDA”

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*

Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603